Jacquelynne Cervantes

Dr. Jacquelynne Cervantes

Universidad Nacional Autónoma de México, Mexico City, Ciudad de México, Mexico
orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
IMIvan Ramos Martínez
Ivan Ramos Martínez
EMEdgar Gustavo Ramos Martínez
Edgar Gustavo Ramos Martínez
RSRene Segura-Velazquez
Rene Segura-Velazquez
MSManuel Saavedra-Montañez
Manuel Saavedra-Montañez
JCJacquelynne Cervantes
Jacquelynne Cervantes
JSJose Ivan Sanchez-Betancourt
Jose Ivan Sanchez-Betancourt
Sialic acids and heparan sulfates make up the outermost part of the cell membrane and the extracellular matrix. Both structures are characterized by being negatively charged, serving as receptors for various pathogens, and are highly expressed in the respiratory and digestive tracts. Numerous viruses use heparan sulfates as receptors to infect cells; in this group are HSV, HPV, and SARS-CoV-2. Other viruses require the cell to express sialic acids, as is the case in influenza A viruses and adenoviruses. This review aims to present, in a general way, the participation of glycoconjugates in viral entry, and therapeutic strategies focused on inhibiting the interaction between the virus and the glycoconjugates. Interestingly, there are few studies that suggest the participation of both glycoconjugates in the viruses addressed here. Considering the biological redundancy that exists between heparan sulfates and sialic acids, we propose that it is important to jointly evaluate and design strategies that contemplate inhibiting the interactions of both glycoconjugates. This approach will allow identifying new receptors and lead to a deeper understanding of interspecies transmission.

28 February 2018 in Nutrients
Verified
Journal Article
Open access
PDF file
CTCeleste Trejo
Celeste Trejo
MMMarisol Méndez-Martínez
Marisol Méndez-Martínez
Alejandro Zamilpa AlvarezAlejandro Zamilpa Alvarez
Alejandro Zamilpa Alvarez
EJEnrique Jimenez-Ferrer
Enrique Jimenez-Ferrer
Ma Dolores Pérez GarcíaMa Dolores Pérez García
Ma Dolores Pérez García
GRGabriela Rosas
Gabriela Rosas
Inflammation and oxidative stress play major roles in endothelial dysfunction, and are key factors in the progression of cardiovascular diseases. The aim of this study was to evaluate in vitro the effect of three subfractions (SFs) from the Cucumis sativus aqueous fraction to reduce inflammatory factors and oxidative stress induced by angiotensin II (Ang II) in human microvascular endothelial cells-1 (HMEC-1) cells. The cells were cultured with different concentrations of Ang II and 0.08 or 10 μg/mL of SF1, SF2, or SF3, or 10 μmol of losartan as a control. IL-6 (Interleukin 6) concentration was quantified. To identify the most effective SF combinations, HMEC-1 cells were cultured as described above in the presence of four combinations of SF1 and SF3. Then, the effects of the most effective combination on the expression of adhesion molecules, the production of reactive oxygen species (ROS), and the bioavailability of nitric oxide (NO) were evaluated. Finally, a mass spectrometry analysis was performed. Both SF1 and SF3 subfractions decreased the induction of IL-6 by Ang II, and C4 (SF1 and SF3, 10 μg/mL each) was the most effective combination to inhibit the production of IL-6. Additionally, C4 prevented the expression of adhesion molecules, reduced the production of ROS, and increased the bioavailability of NO. Glycine, arginine, asparagine, lysine, and aspartic acid were the main components of both subfractions. These results demonstrate that C4 has anti-inflammatory and antioxidant effects.


20 August 2018 in Transboundary and Emerging Diseases
Verified
Journal Article
Closed access
PDF file
MSManuel Saavedra-Montañez
Manuel Saavedra-Montañez
LVLuis Vaca
Luis Vaca
HRHumberto Ramírez‐Mendoza
Humberto Ramírez‐Mendoza
CGCarmen Gaitán‐Peredo
Carmen Gaitán‐Peredo
RBRebeca Bautista‐Martínez
Rebeca Bautista‐Martínez
JSJose Ivan Sanchez-Betancourt
Jose Ivan Sanchez-Betancourt

27 September 2022 in Vaccine
Verified
Journal Article
Closed access
JCJacquelynne Cervantes
Jacquelynne Cervantes
SRSergio Rosales-Mendoza
Sergio Rosales-Mendoza
CCCARLOS CABELLO-GUTIERREZ
CARLOS CABELLO-GUTIERREZ
LMLaura Montero
Laura Montero
JAJuan Alberto Hernandez Aceves
Juan Alberto Hernandez Aceves
ESEdda Sciutto
Edda Sciutto

1 July 2021 in Molecular Immunology
Verified
Journal Article
Closed access
JVJuan Voutssas-Lara
Juan Voutssas-Lara
JCJacquelynne Cervantes
Jacquelynne Cervantes
MHMarisela Hernández
Marisela Hernández
RBRaúl J. Bobes
Raúl J. Bobes
ELEdmundo Lamoyi
Edmundo Lamoyi
ESEdda Sciutto
Edda Sciutto